Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Pan-Facial Botulinum Toxin

Description

In a presentation on pan-facial botulinum toxin (commonly known as Botox), the speaker emphasizes the benefits of treating multiple facial areas instead of just one. They express their preference not to refer to the substance as 'juice,' instead using the term 'toxin,' which aligns with patient understanding. The speaker shares insights gained from their collaboration with Dr. Jean Carruthers on a special issue focusing on neurotoxins for dermatologic surgeries, set to publish in September. They also discuss their personal approach to aesthetics, using various techniques and specific dosages for different facial regions, while cautioning against self-injection to maintain an objective perspective. Throughout the presentation, there is a balance of technique sharing and humorous commentary, reinforcing the importance of patient care, nuanced injecting practices, and the significance of managing patient expectations. The presentation also highlights the challenges and subtleties of treating areas such as the glabella, forehead, and neck, while touching on the relative effectiveness and appropriateness of using toxin in off-label areas, like the lower face. Overall, the speaker conveys a thoughtful approach to aesthetic treatment, advocating for comprehensive assessments and patient communication.

View more

Conclusions

  • The use of botulinum toxin should be approached holistically, treating multiple facial areas rather than isolated spots.
  • Patients may be more receptive to botulinum treatments when they observe immediate results, such as the reduction of crow's feet.
  • Injecting botulinum toxin in areas like the glabella complex and forehead can lead to improved patient satisfaction and aesthetic outcomes.
  • Careful consideration should be given to muscle anatomy to avoid complications such as brow ptosis and adverse changes in facial expression.
  • Utilizing specific injection techniques and dosages for different facial muscles can enhance the effectiveness of treatment and minimize discomfort.
  • The application of botulinum toxin can reduce muscular tension, which may lead to alleviation of conditions like bruxism and associated migraines.
  • While off-label uses of neurotoxins like for the nasolabial fold and mentalis crease exist, sufficient patient education is essential regarding potential risks and benefits.
  • For best results, neurotoxin treatments should be complemented with other procedures when appropriate, such as dermal fillers.
  • Managing treatment expectations and addressing patient concerns such as bruising and downtime are key to maintaining patient trust and satisfaction.